Monroe County NY Legislature Honors Allergy Advocacy Association

It was certainly a busy month in November for your Allergy Advocacy Association. In addition to the gala and a feature article in the Democrat and Chronicle, we received a proclamation from Monroe County legislators in recognition of all our efforts to keep our community members with life-threatening allergies safe. The proclamation specifically mentioned our efforts to help pass the New York State Emergency Allergy Treatment Act, allowing restaurants and other public venues to stock epinephrine. We were very pleased to be recognized and plan to accomplish even more in the New Year.

Monroe County NY Legislature Honors Allergy Advocacy Association
Issues Proclamation of Recognition and Appreciation

November 13^th, 2018

During the November meeting of the Monroe County Legislature, a proclamation was issued recognizing the Allergy Advocacy Association. Dr. Joe Carbone, president of the county legislature, presented the award to Jon Terry, founder of the association. Mike Zale, representative for Legislature District 20, was the primary sponsor and Mike Rockow from District 2 acted as the co-sponsor.

Continue Reading

EAI Device Incident Sparks Concern on NJ Campus

It’s very sad to learn that public safety officials at Seton Hall University as well as local police officers were so afraid of a lawsuit that they refused to administer epinephrine to a student experiencing anaphylaxis. Fortunately the student’s friend was willing to administer it, as by the time an ambulance arrived it might have been too late. The university now realizes training of public safety officers needs to take place and have been in contact with the Department of Health Services to arrange it. No mention is made of training for the South Orange Police Department.

EAI Device Incident Sparks Concern on NJ Campus

By Staff Writer Nicholas Kerr
October 3^rd, 2018

A Seton Hall University student is alleging her health and safety were put at risk two weeks ago when Public Safety and the South Orange Police Department (SOPD) failed to administer an EpiPen to counter an allergic reaction.

Continue Reading

November Allergy Action Awards Gala Update

November Allergy Action Awards Gala Update

Join us for our first annual Rochester Community Action Awards event! It will be held Thursday, November 15 from 6-9 p.m. at ARTISANworks on Blossom Road in Rochester. Read here to find out who the first well-deserved recipients of the awards will be. We could really use your help to find sponsors for the event and items for a silent auction. Please contact Patrick Morris at This email address is being protected from spambots. You need JavaScript enabled to view it. if you have any suggestions.

We sincerely thank you and will look forward to seeing you on November 15!

October 17^th, 2018
Allergy Advocacy Association’s
Rochester Community Action Awards
First Annual Fundraising Gala

This event will honor leaders of our community who have made invaluable contributions to advocacy, management and research of life-threatening allergies.

Thursday, November 15, 2018
6 – 9 pm
ARTISANworks
565 Blossom Road
Rochester, NY 14610

Our featured honorees are:

Dr. John J. Condemi
We are pleased to honor Dr. Condemi with our very first John J. Condemi Award for his leading role in anaphylaxis research, treatment and advocacy in the Rochester area.

Continue Reading

FDA OKs Another Alternative to EpiPen

If you have been concerned about the shortage of epinephrine as well as its rising costs, rest assured help is on the way. In late September 2018, the FDA approved a new low-dose version of Symjepi that is a prefilled injection syringe. For those used to an auto-injector, additional training may be necessary, but the manufacturer claims it is very easy to use. They state the low-dose version will be ready as soon as possible, but the higher dose version that was approved in 2017 is still not available.

FDA OKs Another Alternative to EpiPen

By Kathleen Doheny
Sept. 27, 2018

On Thursday, the FDA approved a low-dose version of Symjepi, an injected epinephrine to treat life-threatening allergies. The new alternative, when available, may ease ongoing shortages of other epinephrine products such as Epi-Pen.

While the Epi-Pen, and others like Auvi-Q, is an auto-injected device, Symjepi is a prefilled injection syringe, so experts expect it to take time for users to get used to the new device, which aims to prevent the life-threating allergic reaction known as anaphylaxis.

Continue Reading